Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide

In order to evaluate the main adverse effects of drug protocols using bortezomib and/or thalidomide for the treatment of multiple myeloma, we conducted a prospective study. Data were collected through interviews, clinical observation, and from hospital records. A total of 59 patients were included....

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, T.B.M., Hallack, A.E., Atalla, A., Ribeiro, L.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2016
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932818/
https://www.ncbi.nlm.nih.gov/pubmed/27254660
http://dx.doi.org/10.1590/1414-431X20165128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932818/
https://www.ncbi.nlm.nih.gov/pubmed/27254660
http://dx.doi.org/10.1590/1414-431X20165128

Ejemplares similares